Jennifer G. Brown

Preclinical Development of MGC018, a Duocarmycin-based Antibody–drug Conjugate Targeting B7-H3 for Solid Cancer

Juniper A. Scribner, Jennifer G. Brown, Thomas Son et al. · Molecular Cancer Therapeutics · 2020 · 148 citations

Transcription Factor NF-κB Differentially Regulates Death Receptor 5 Expression Involving Histone Deacetylase 1

Shashirekha Shetty, Bonnie A. Graham, Jennifer G. Brown et al. · Molecular and Cellular Biology · 2005 · 136 citations · Full text

Hdac Inhibitors, Apoptosis, Immunology +20

Engineering and Biological Characterization of VB6-845, an Anti-EpCAM Immunotoxin Containing a T-cell Epitope-depleted Variant of the Plant Toxin Bouganin

Jeannick Cizeau, Danielle M. Grenkow, Jennifer G. Brown et al. · Journal of Immunotherapy · 2009 · 79 citations

Toxinology, Immunology, Immunodominance +17

Development of MGD007, a gpA33 x CD3-Bispecific DART Protein for T-Cell Immunotherapy of Metastatic Colorectal Cancer

Paul A. Moore, Kalpana Shah, Yinhua Yang et al. · Molecular Cancer Therapeutics · 2018 · 71 citations

MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell Malignancies

Liqin Liu, Chia‐Ying K. Lam, Vatana Long et al. · Clinical Cancer Research · 2016 · 68 citations · Full text